Reviewed June 2007
What is holocarboxylase synthetase deficiency?
Holocarboxylase synthetase deficiency is an inherited disorder in which the body is unable to use the vitamin biotin effectively. This disorder is classified as a multiple carboxylase deficiency, a group of disorders characterized by impaired activity of certain enzymes that depend on biotin.
The signs and symptoms of holocarboxylase synthetase deficiency typically appear within the first few months of life, but the age of onset varies. Affected infants often have difficulty feeding, breathing problems, a skin rash, hair loss (alopecia), and a lack of energy (lethargy). Immediate treatment and lifelong management with biotin supplements may prevent many of these complications. If left untreated, the disorder can lead to delayed development, seizures, and coma. These medical problems may be life-threatening in some cases.
How common is holocarboxylase synthetase deficiency?
The exact incidence of this condition is unknown, but it is estimated to affect 1 in 87,000 people.
What genes are related to holocarboxylase synthetase deficiency?
Mutations in the HLCS gene cause holocarboxylase synthetase deficiency.
The HLCS gene provides instructions for making an enzyme called holocarboxylase synthetase. This enzyme is important for the effective use of biotin, a B vitamin found in foods such as liver, egg yolks, and milk. Holocarboxylase synthetase attaches biotin to certain enzymes that are essential for the normal production and breakdown of proteins, fats, and carbohydrates in the body. Mutations in the HLCS gene reduce the enzyme's ability to attach biotin to these enzymes, preventing them from processing nutrients properly and disrupting many cellular functions. These defects lead to the serious medical problems associated with holocarboxylase synthetase deficiency.
Read more about the HLCS gene.
How do people inherit holocarboxylase synthetase deficiency?
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Where can I find information about treatment for holocarboxylase synthetase deficiency?
These resources address the management of holocarboxylase synthetase deficiency and may include treatment providers.
You might also find information on treatment of holocarboxylase synthetase deficiency in
Educational resources and Patient support.
Where can I find additional information about holocarboxylase synthetase deficiency?
You may find the following resources about holocarboxylase synthetase deficiency helpful. These materials are written for the general public.
You may also be interested in these resources, which are designed for healthcare professionals and researchers.
- Gene Tests
- DNA tests ordered by healthcare professionals
-
- PubMed - Recent literature
- Online Books - Medical and science texts
- OMIM - Genetic disorder catalog
What other names do people use for holocarboxylase synthetase deficiency?
- Early-Onset Biotin-Responsive Multiple Carboxylase Deficiency
- Early-Onset Combined Carboxylase Deficiency
- HLCS deficiency
- Infantile Multiple Carboxylase Deficiency
- Multiple Carboxylase Deficiency, Neonatal Form
What if I still have specific questions about holocarboxylase synthetase deficiency?
Where can I find general information about genetic conditions?
The Handbook provides basic information about genetics in clear language.
These links provide additional genetics resources that may be useful.
What glossary definitions help with understanding holocarboxylase synthetase deficiency?
The resources on this site should not be used as a substitute for
professional medical care or advice. Users seeking information about
a personal genetic disease, syndrome, or condition should consult with a qualified
healthcare professional.
See How can I find a genetics professional in my area? in the Handbook.
